Dalton Pharma News

News & Events

Welcome to Dalton Pharma Services News and Events.

On this page you will find our current and past news releases and a list of event happenings. If you can't find what you are looking for, please contact us and we will be happy to provide you with assistance.

5/9/2017 15:50 Dalton Announces a Drug Development and GMP Manufacturing Services Agreement with Arch Biopartners

Dalton Pharma Services, a leading pharmaceutical cGMP contract manufacturing company, today announced the signing of a drug development and manufacturing services agreement with Arch Biopartners, Inc., a Canadian biotechnology firm focused on the development of technologies that have the potential to make a significant medical or commercial impact.

3/9/2017 09:00 An Interview With Peter Pekos, President & CEO, Dalton Pharma Services

Pharmaceutical Outsourcing conducts an interview with Peter Pekos, President & CEO, Dalton Pharma Services.

2/28/2017 09:00 Dalton Pharma Services Wins 2017 CMO Leadership Awards

Dalton Pharma Services, a leading pharmaceutical cGMP contract manufacturing company, is pleased to announce that it has been recognized for a second consecutive year as a Life Science Leader CMO Leadership Award recipient, which recognizes the highest quality contract manufacturing organizations as chosen by real customers, in five core categories: Reliability, Capabilities, Expertise, Compatibility and Development.

1/17/2017 09:00 Dalton Announces Drug Development and Manufacturing Services Agreement with Cerium Pharmaceuticals

Dalton Pharma Services today announced the signing of a drug development and manufacturing services agreement with Cerium Pharmaceuticals, Inc., an emerging biopharmaceutical company based in Gaithersburg, Maryland, USA.

1/10/2017 09:00 Valued Employees Boost the Bottom Line

A key factor in our success in developing new medicines that are safe and effective.

12/20/2016 09:00 Dalton Enters Into Agreement With the USAMMDA in Support of the US Army’s Drug Development Program

Dalton entered into an Agreement with the US Army Medical Materiel Development Activity (USAMMDA) and will provide cGMP sterile powder filling, aseptic liquid filling, and ICH stability testing in support of the US Army’s anti-malarial drug development program.

12/7/2016 09:00 Perspective On Trade Agreements

“I love trade.  I’m a free trader, 100 percent.  But we need smart people making the deals, and we don’t have smart people making the deals.” - Donald Trump, US President Elect

11/22/2016 09:00 Dalton Pharma Services officially certified as a Great Place to Work

Dalton Pharma Services officially certified as a Great Place to Work following independently-conducted employee surveys

8/30/2016 18:25 Dalton Announces Completion of a Major Expansion in Sterile Filling and API Manufacturing

Dalton Pharma Services, a privately owned Canadian pharmaceutical services provider to leading pharmaceutical and biotechnology companies, announced today the completion of a $5 million expansion in sterile filling and API manufacturing at its cGMP facility in Toronto, Canada.

6/29/2016 09:00 Dalton Announces Addition of Flow Chemistry Technology

Dalton Pharma Services announced today the addition of Flow Chemistry Reactor Technology to the services offered to its clients. This exciting new technology is now part of Dalton’s extensive arsenal of capabilities in the area of custom synthesis and process development and has many benefits including increased scalability, flexibility, and process control.